NSE filing, NSE: CARERATING. Summary written from the filing by ALFA Finder's alert engine.
CARE Ratings Ltd: key numbers
- Share price
- ₹1,613.20
- Market cap
- ₹4,861 Cr
- Revenue (annual)
- ₹473.1 Cr
- Net profit (annual)
- ₹171.2 Cr
- P/E (TTM)
- 27.4×Sector 19.7×
- Promoter holding
- 0.00%+0.00% QoQ
- FII holding
- 23.61%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from CARE Ratings Ltd
All →CARE Ratings Results Update
CARE Ratings reported strong Q2 and H1 FY27 operating income and profit growth. The board also declared an interim dividend of Rs 10 per share.
CARE Ratings Q2 FY27 Results: Net Profit ₹72.4 Cr, Up 26.6% YoY
CARE Ratings Ltd reported revenue from operations of ₹164.1 Cr (+20.3% YoY) and net profit of ₹72.4 Cr (+26.6% YoY) for Q2 FY27.
- Key figure
- Net profit ₹72.4 Cr · +26.6% YoY
CARE Ratings Merger & Restructuring
CARE Ratings executed SPAs to sell 9.90% stakes each in subsidiary CareEdge Global IFSC to SBI and NSE IFSC. CARE will retain 80.20% post-closing.
CARE Ratings Other Announcement
CARE Ratings Ltd has filed its quarterly shareholding pattern as of September 30, 2026, in compliance with SEBI regulatory requirements.
CARE Ratings Board Meeting Date
CARE Ratings Limited intimated a board meeting scheduled for 29 October 2026 to consider unaudited half-yearly financial results and an interim dividend. No figures or decisions have been made yet.
CARE Ratings Earnings Call Transcript: Key Takeaways
CARE Ratings Q1 FY27 presentation highlights 18.9% consolidated revenue growth and 24.6% PAT growth. Expansion into global sovereign ratings and ESG services drives non-ratings momentum.
Other employee stock options announcements
All →JSW Energy Employee Stock Options
JSW Energy's employee welfare trust transferred 10,044 shares to employees after ESOP option exercises. The off-market transfer was valued at about Rs 0.01 Crore.
- Value
- ₹0.01 Cr
Indegene Employee Stock Options
Indegene Limited allotted 52,194 equity shares under its ESOP schemes, raising paid-up capital to Rs.48.21 Crore. No cash fund raise is involved, so no event value applies.
Raymond Employee Stock Options
Raymond allotted 1,56,784 equity shares to its ESOP Trust under the Raymond Employees Stock Option Plan 2023. Paid-up capital rose to Rs. 66,73,05,150.
Alivus Life Sciences Employee Stock Options
Alivus Life Sciences allotted 1,95,833 equity shares to an employee who exercised ESOP options under its 2021 scheme. Paid-up capital rises to Rs. 24.59 Crore.
Archean Chemical Industries Employee Stock Options
Archean Chemical allotted 6,143 equity shares to one grantee under its ESOP 2022 on 29-Oct-2026. Paid-up capital rose to 12,34,64,537 shares.
Intellect Design Arena Employee Stock Options
Intellect Design Arena granted 1,83,500 RSUs to 19 associates under its ISOP/RSU 2016 scheme. This ESOP grant carries no transaction value for the event.
- Execution
- Vesting over 1st to 5th year from grant